Sky Century InvestmentSKYI 25 Gross Margin % is 74.42% as of Feb. 2026, which is 132% above its 10-year median of 32.14. GuruFocus rates SKYI with a GF Score™ of 25/100. The stock has 5 warning signs investors should review. Among 937 Drug Manufacturers companies, Sky Century Investment ranks better than 52.4% on this metric.
SKYI's Gross Margin % is ranked better than 52.4% of 937
companies
in the Drug Manufacturers industry
Industry Median: 48.46
vs SKYI: 50.00
Sky Century Investment had a gross margin of 74.42% for the quarter that ended in Feb. 2026 => Durable competitive advantage
The 5-Year average Growth Rate of Gross Margin for Sky Century Investment was 0.00% per year.
Sky Century Investment (OTCPK:SKYI) Gross Margin % Explanation
Warren Buffett believes that firms with excellent long term economics tend to have consistently higher margins.
Durable competitive advantage creates a high Gross Margin % because of the freedom to price in excess of cost. Companies can be categorized by their Gross Margin %
1. Greater than 40% = Durable competitive advantage
2. Less than 40% = Competition eroding margins
3. Less than 20% = no sustainable competitive advantage
Consistency of Gross Margin is key
Sky Century Investment had a gross margin of 74.42% for the quarter that ended in Feb. 2026 => Durable competitive advantage
Be Aware
If a company loses its competitive advantages, usually its gross margin declines well before its sales declines. Watching Gross Margin % and Operating Margin % closely helps avoid value trap situations.
Sky Century Investment Gross Margin % Related Terms
Sky Century Investment Gross Margin % Historical Data
* Premium members only.
The historical data trend for Sky Century Investment's Gross Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
SKYI vs IMCC, PLSH, BSPK: Gross Margin % Comparison
For the Drug Manufacturers - Specialty & Generic subindustry, Sky Century Investment's Gross Margin %, along with its competitors' market caps and Gross Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Sky Century Investment Gross Margin % vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Sky Century Investment's Gross Margin % distribution charts can be found below:
* The bar in red indicates where Sky Century Investment's Gross Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
A positive Gross Profit is only the first step for a company to make a net profit. The gross profit needs to be big enough to also cover related labor, equipment, rental, marketing/advertising, research and development and a lot of other costs in selling the products.
Sky Century Investment (SKYI) has a Gross Margin % of 74.42% as of Feb. 2026. Gross margin is the ratio of total gross profit to net sales. View historical data on Sky Century Investment and its competitors. This is 132% above median its historical median of 32.14. Over the past decade, Sky Century Investment's Gross Margin % has ranged from 31.58 to 50.00. According to the industry distribution chart, Sky Century Investment ranks #446 out of 937 companies in the Drug Manufacturers industry, placing it in the top 47.6%.
Is Sky Century Investment's Gross Margin % too high?
Sky Century Investment's current Gross Margin % of 74.42% is 132% above median its 10-year median of 32.14. Over the past 10 years, this metric has ranged from a low of 31.58 to a high of 50.00. The Drug Manufacturers industry median Gross Margin % is 48.46. Sky Century Investment's value of 74.42% is 53.6% above this industry median. Based on the distribution chart, Sky Century Investment ranks #446 out of 937 companies in the Drug Manufacturers industry, which is above the industry midpoint. Overall, Sky Century Investment has a GF Score™ of 25/100, reflecting its overall financial health beyond just this single metric.
How does Sky Century Investment's Gross Margin % compare to IMCC and PLSH?
According to the Drug Manufacturers industry distribution chart, Sky Century Investment ranks #446 out of 937 companies for Gross Margin %. This puts Sky Century Investment in the upper half of its industry. The industry median Gross Margin % is 48.46. Sky Century Investment's value of 74.42% is 53.6% above this benchmark. Historically, Sky Century Investment's own Gross Margin % has ranged from 31.58 to 50.00 over the past decade. While the company's 10-year median is 32.14 vs. the industry median of 48.46, Sky Century Investment has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Gross Margin % for a Drug Manufacturers company?
The median Gross Margin % among Drug Manufacturers companies is 48.46, based on 937 companies in the industry. Companies in the top quartile (top 25%) have a Gross Margin % significantly above this median, while those in the bottom quartile fall well below. However, Gross Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Sky Century Investment's current Gross Margin % of 74.42% is 53.6% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Gross Margin % mean?
A high Gross Margin % can signal that a stock is expensive relative to its fundamentals. Gross margin is the ratio of total gross profit to net sales. View historical data on Sky Century Investment and its competitors. For the Drug Manufacturers industry, the median Gross Margin % is 48.46 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Sky Century Investment's current Gross Margin % is 74.42%, which is 132% above median its own 10-year median of 32.14. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Sky Century Investment stock overvalued right now?
Sky Century Investment (SKYI) has a current Gross Margin % of 74.42%. The current Gross Margin % is 74.42%, which is 132% above median its 10-year median of 32.14 and 53.6% above the Drug Manufacturers industry median of 48.46. Sky Century Investment's overall GF Score™ is 25/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Gross Margin % calculated?
Gross Margin % is calculated from a company's financial statements. For Sky Century Investment (SKYI), the current Gross Margin % is 74.42% as of Feb. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Sky Century Investment Inc operates four primary business lines, with profits generated from IT Services, including Technical Support and Server Leasing, and from the sale of RSS feeds and Podcasts. The IT Services segment provides ongoing technical support, maintenance, system upgrades, and high-performance server leasing, supporting growing demand for cloud solutions, data management, and network infrastructure. The Company also owns the Cannabis News application, a mobile platform that aggregates cannabis-related news from diverse sources and delivers real-time updates, though it is not commercially viable and has not generated revenue to date. The Company operates in competitive markets across IT services, marketing services, RSS feed services, and the cannabis industry.
25GF Score
Get the complete analysis for SKYI
Gross Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SKYI has been successfully added to your 
